LEADER 03862nam 22009733a 450 001 9910367569503321 005 20250203235431.0 010 $a9783039212606 010 $a3039212605 024 8 $a10.3390/books978-3-03921-260-6 035 $a(CKB)4100000010106051 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/54903 035 $a(ScCtBLL)7f02ab9e-237b-48b3-87ad-13eaa3682971 035 $a(OCoLC)1163822591 035 $a(EXLCZ)994100000010106051 100 $a20250203i20192019 uu 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aNucleic Acid Architectures for Therapeutics, Diagnostics, Devices and Materials$fKirill Afonin 210 1$aBasel, Switzerland :$cMDPI,$d2019. 215 $a1 electronic resource (186 p.) 311 08$a9783039212590 311 08$a3039212591 330 $aNucleic acids (RNA and DNA) and their chemical analogs have been utilized as building materials due to their biocompatibility and programmability. RNA, which naturally possesses a wide range of different functions, is now being widely investigated for its role as a responsive biomaterial which dynamically reacts to changes in the surrounding environment. It is now evident that artificially designed self-assembling RNAs, that can form programmable nanoparticles and supra-assemblies, will play an increasingly important part in a diverse range of applications, such as macromolecular therapies, drug delivery systems, biosensing, tissue engineering, programmable scaffolds for material organization, logic gates, and soft actuators, to name but a few. The current exciting Special Issue comprises research highlights, short communications, research articles, and reviews that all bring together the leading scientists who are exploring a wide range of the fundamental properties of RNA and DNA nanoassemblies suitable for biomedical applications. 610 $acotranscriptional folding 610 $aRNA 610 $aconditionally activated 610 $ai-motif DNA 610 $aspinal cord tumor 610 $afluorescence 610 $adynamic 610 $astability 610 $afunctional RNA 610 $aribozyme 610 $abiological media 610 $aRNA aptamers 610 $agene therapy 610 $abiosensors 610 $aviral vector 610 $aganciclovir 610 $aRNA self-assembly 610 $aRNA nanoparticle 610 $agene delivery 610 $ariboswitch 610 $anon-viral gene delivery 610 $aNANPs 610 $asilver nanoclusters 610 $asmall-angle neutron scattering 610 $acontrast variation 610 $aaptamers 610 $aRNA logic 610 $afluorogenic RNA 610 $aglioblastoma multiforme 610 $aRNA interference 610 $anucleic acid nanoparticles 610 $aimmunostimulation 610 $aaggregation 610 $asmall-angle X-ray scattering 610 $anon-viral vector 610 $alight-up aptamer 610 $anucleic acid therapeutic 610 $alive-cell imaging 610 $aDNA nanotechnology 610 $anucleic acid computing 610 $ananopores 610 $astructural characterization 610 $asiRNA 610 $asuicide gene therapy 610 $anucleic acid nanoparticle 610 $acytosine rich sequences 610 $aRNA nanotechnology 610 $alogic gates 610 $aserum 610 $aconditional activation 700 $aAfonin$b Kirill$01305966 801 0$bScCtBLL 801 1$bScCtBLL 906 $aBOOK 912 $a9910367569503321 996 $aNucleic Acid Architectures for Therapeutics, Diagnostics, Devices and Materials$93028074 997 $aUNINA